Algen Biotechnologies

San Francisco, CALife SciencesCohort: 2019-2020

Algen Biotechnologies is building a CRISPR-based screening platform to decode functional gene networks of complex diseases and accelerate cancer therapeutics discovery. Our platform allows for the construction of high-resolution disease maps and identification of novel drugs that selectively reverse cancer signaling while minimizing adverse events in healthy cells and tissue.